Preliminary results from a preclinical study demonstrated statistically significant increase in MHC-I expression following ...
Introducing a new RNA-seq platform for intracellular multimodal profiling that could transform cancer research and ...
Phase 2a data show zero cough and 60% lower treatment-related diarrhea than placebo despite higher nintedanib use in the ...
Mirai Bio, the innovation delivery partner for companies developing next generation nucleic acid medicines, today announced new preclinical data from an oral presentation at the American Society of ...
New immunologic and biomarker data supports the potential of ITK inhibition with soquelitinib to increase persistent Treg ...
Allogeneic hematopoietic cell transplantation (alloHCT) using tremtelectogene empogeditemcel (trem-cel), a CRISPR–Cas9–edited ...
Intestinal blooms of Ruminococcus gnavus, which produce a novel lipoglycan toxin, are linked to a distinct lupus nephritis ...
Get our picks of what to watch out for at SLAS Europe 2026, with key highlights from the program and opportunities not to be ...
A 50-year-old woman was admitted to the hospital because of vaginal bleeding and anemia. She had a history of fibroids and 1 month of progressive thrombocytopenia. A diagnosis was made.
Resources for industrial and academic research and analysis. Find answers to your questions working with our world class laboratories and technicians.
The parties aim to incorporate iFast's rapid AST system in clinical settings and develop evidence to support broader adoption by the NHS and other UK healthcare organizations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results